Daiichi Sankyo's Blood Thinner Works as Well as Warfarin in Trial

Daiichi Sankyo's blood thinner edoxaban proved at least as effective in a major trial as the widely used warfarin in reducing the risk of stroke among patients with an irregular heartbeat called atrial fibrillation



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303985504579208292473548608.html?mod=pls_whats_news_us_business_f

via IFTTT